Women and Lung Cancer Research and Preventive Services Act of 2025
Introduced Mar 25, 2025 by Rep. Brendan F. Boyle
The House passed it. The Senate has to pass it before it can reach the President.
This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.
The review must
report on the status of existing research and current knowledge gaps;
identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
Read the full summary on Congress.govSummary by the Congressional Research Service.
No recorded roll-call vote on this bill — it may have passed by voice vote or unanimous consent, which don't record individual votes.
- Apr 22, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
- Apr 21, 2026Motion to reconsider laid on the table Agreed to without objection.
- Apr 21, 2026On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
- Apr 21, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
- Apr 21, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
- Apr 21, 2026Considered under suspension of the rules. (consideration: CR H3020-3021)
- Apr 21, 2026Mrs. Harshbarger moved to suspend the rules and pass the bill.
- Nov 18, 2025Placed on the Union Calendar, Calendar No. 332.
- Nov 18, 2025Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
- Apr 29, 2025Ordered to be Reported by Voice Vote.
- Apr 29, 2025Committee Consideration and Mark-up Session Held
- Mar 25, 2025Referred to the House Committee on Energy and Commerce.
- Mar 25, 2025Introduced in House